RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
NAME: XXXXXXXXXXXXXXXXXXXXXXXXX BRANCH OF SERVICE: ARMY
CASE NUMBER: PD1200492 DATE OF PERMANENT SEPARATION: 20030623
BOARD DATE: 20130228 DATE OF PLACEMENT ON TDRL: 20020502
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty SPC/E-4 (25V/Combat Documentation and Production
Specialist), medically separated for asthma. Despite treatment for asthma, the CI could not be
adequately rehabilitated to meet the physical requirements of his Military Occupational
Specialty (MOS) or satisfy physical fitness standards. The CI was originally issued a permanent
P3 profile in 1998 and was referred for a Medical Evaluation Board (MEB). The MEB forwarded
asthma and allergic rhinitis to the Physical Evaluation Board (PEB). In March 2002 the PEB
adjudicated asthma as unfitting, rated 30% with likely application of the Veterans Affairs
Schedule for Rating Disabilities (VASRD). The PEB also determined that a permanent evaluation
of the CIs impairments was not yet possible. The allergic rhinitis was determined to be not
unfitting and no rating was assigned. The CI concurred with these findings and he was placed
on the Temporary Disability Retired List (TDRL). The CI was evaluated approximately a year
later and in May 2003, the PEB rendered a final disability rating of 0%. The CI concurred with
the PEBs findings and waived a formal hearing but also wrote a letter asking to remain on
active duty. The US Army Physical Disability Agency (USAPDA) determined the PEB had
properly adjudicated the case and the CI was permanently separated.
CI CONTENTION: Asthma I have asthma. While on active duty I took a methacholine
challenge test. The only way to verify asthma. They put me out of the army due this test. After
one year I took re-evalution for asthma. The medical facility gave me a PFT test and said I no
longer had asthma. My PFTs have always been in normal range. I had the VA give me another
methacholine challenge. The results show I was asthmatic.
SCOPE OF REVIEW: The Boards scope of review is defined in Department of Defense
Instruction (DoDI) 6040.44, Enclosure 3, paragraph 5.e. (2). It is limited to those conditions
determined by the PEB to be unfitting for continued military service and those conditions
identified but not determined to be unfitting by the PEB when specifically requested by the CI.
Ratings for unfitting conditions will be reviewed in all cases. The rated asthma as requested for
consideration meets the criteria prescribed in DoDI 6040.44 for Board purview. Any conditions
or contention not requested in this application, or otherwise outside the Boards defined scope
of review, remain eligible for future consideration by the Army Board for Correction of Military
Records.
TDRL RATING COMPARISON:
Final Service IPEB Dated 20030507
VA - (10 Mos. Pre Final Separation)
On TDRL 20020502
Condition
Code
Rating
Exam
Condition
Code
Rating
TDRL
Sep.
Asthma
6602
30%
0%
Asthma
6602
30%
20020820
Allergic Rhinitis
Not Unfitting
N/A
Allergic Rhinitis
6522
0%
20020820
.No Additional MEB/PEB Entries.
Other x 10
20020820
Combined: 0%
Combined: 30%
Original VA Rating effective 20020503 per VARD 20021009.
ANALYSIS SUMMARY: The Boards authority as defined in DoDI 6040.44, resides in evaluating
the fairness of Disability Evaluation System (DES) fitness determinations and rating decisions for
disability at the time of separation. The Board utilizes VA evidence proximal to separation in
arriving at its recommendations; and, DoDI 6040.44 defines a 12-month interval for special
consideration to post-separation evidence. Post-separation evidence is probative only to the
extent that it reasonably reflects the disability and fitness implications at the time of
separation.
Asthma. The initial MEB narrative summary (NARSUM) prior to TDRL entry was completed in
January 2002. It stated the CI had been diagnosed with asthma after a methacholine challenge
test (MCT) in 1997. Pre-bronchodilator pulmonary function testing (PFTs) was normal in
December 2001 and no post-bronchodilator testing was completed. The pertinent findings are
noted in the chart below. A VA Compensation and Pension (C&P) examination was completed
approximately 2 months after TDRL entry and it documented the use of Singulair, Advair, and
Proventil. PFTs were completed, the examination did not state whether the testing was done
pre-or post-bronchodilator, the results were within normal limits. The Board directs attention
to its rating recommendation for the time of TDRL entry based on the above evidence. The PEB
determined the asthma condition was not stable for rating and the CI was placed on the TDRL
instead of being permanently separated. The PEB rated the condition 6602 Asthma at 30%
based on the daily use of both inhaled anti-inflammatory and bronchodilator medication
(Advair) and oral bronchodilator medication (Singulair). The VA also assigned a 30% rating
based on medications. There is no evidence of intermittent use of systemic steroids or post-
bronchodilator PFT results that would warrant a rating greater than 30%. After due
deliberation, considering all of the evidence and mindful of VASRD §4.3 (reasonable doubt), the
Board concluded that there was insufficient cause to recommend a change in the PEB
adjudication for the asthma condition at TDRL entry.
Pulmonary
Exam
MEB ~4.5 Mo.
Pre-TDRL entry
VA C&P ~2 Mo. Post-TDRL entry
and ~10 Mo. Pre-TDRL Exit
MEB ~2.5 Mo.
Pre-TDRL Exit
FEV1 (%
Predicted)
112%
% not reported
106%
FEV1/FVC
85%
79%
83%
Meds
Daily Singulair and
Advair
Proventil, Advair, and Singulair (Not
using inhaler regularly)
No medications in the past six months
Comments
Pre-Bronchodilator
PFTs: normal
spirometry;
Daily oral bronchodilator therapy;
Normal spirometry ; Not stated if
PFTs are pre-or post-bronchodilator;
PFTs source document missing; not
stated if testing done pre-or post-
bronchodilator; able to run 1+ mile
without any problem; worked
outdoors
§4.97 Rating
30%
30%
0%
A periodic TDRL evaluation was completed approximately 2 months prior to permanent
separation from service. The accompanying NARSUM noted the CI reported that he had quit
smoking 2 months previously and that he had not taken any medication in the previous 6
months. The findings are reported in the chart above. No further information about this
condition is available until PFTs were completed by the VA in September 2010, more than 7
years after the CI separated. A C&P examination completed in October 2010 noted the CI had
normal pre-bronchodilator PFTs and that he was using inhaled anti-inflammatory (Azmacort)
and inhaled bronchodilator (Proventil) medications. The January 2012 VA rating decision
(VARD) related to this examination refers to VA treatment records from 2010 and 2011 but
these are not available in the record. At the C&P examination, the CI reported he required
monthly visits to the emergency room due to his asthma.
The Board directs attention to its rating recommendation based on the above evidence. At the
time of exit from the TDRL, the PEB assigned a 0% rating for 6602 asthma because the CI did
not meet the minimum rating criteria. The 2012 VARD continued the 30% rating for 6602
asthma based medication usage stating there was no evidence to support monthly emergency
room visits. The record does not contain any information about the CIs use of medications
between the time of the periodic TDRL evaluation NARSUM in 2003 and the C&P examination in
2010. There is no evidence to show the CI was taking any asthma medication near the time of
exit from the TDRL and permanent separation from service. After due deliberation, considering
all of the evidence and mindful of VASRD §4.3 reasonable doubt, the Board concluded that
there was insufficient cause to recommend a change in the PEB adjudication for the asthma
condition at the time of TDRL exit and permanent separation from service.
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the asthma condition and IAW VASRD §4.97, the Board
unanimously recommends no change in the PEB adjudication at either the time of TDRL entry
or at the time of TDRL exit and permanent separation from service. There were no other
conditions within the Boards scope of review for consideration.
RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of
the CIs disability and separation determination, as follows:
UNFITTING CONDITION
VASRD CODE
RATING
TDRL
PERMANENT
Asthma
6602
30%
0%
COMBINED
30%
0%
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120602, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans Affairs Treatment Record
XXXXXXXXXXXXXXXXXXXX
Acting Director
Physical Disability Board of Review
SFMR-RB
MEMORANDUM FOR Commander, US Army Physical Disability Agency
(TAPD-ZB / XXXXXXXXXXX), 2900 Crystal Drive, Suite 300, Arlington, VA 22202-3557
SUBJECT: Department of Defense Physical Disability Board of Review Recommendation
for XXXXXXXXXXXXXXXXXXXXXXXX, AR20130005354 (PD201200492)
I have reviewed the enclosed Department of Defense Physical Disability Board of
Review (DoD PDBR) recommendation and record of proceedings pertaining to the
subject individual. Under the authority of Title 10, United States Code, section 1554a,
I accept the Boards recommendation and hereby deny the individuals application.
This decision is final. The individual concerned, counsel (if any), and any Members of
Congress who have shown interest in this application have been notified of this decision
by mail.
BY ORDER OF THE SECRETARY OF THE ARMY:
Encl XXXXXXXXXXXXXXXXXX
Deputy Assistant Secretary
(Army Review Boards)
AF | PDBR | CY2013 | PD 2013 00908
SEPARATION DATE: 20040312 Asthma Condition . The diagnosis in his finding of unfitness for Asthma,VASRD Code 6602, was rated at 30% rather than 10%.
AF | PDBR | CY2012 | PD 2012 01248
The Physical Evaluation Board (PEB) adjudicated the asthma condition as unfitting, rated 10% with application of the Veterans Affairs Schedule for Rating Disabilities (VASRD). The contended conditions adjudicated as not unfitting by the PEB were allergic rhinitis, intermittent non-radiating lower back pain, essential hypertension, chronic gastritis and hypercholesterolemia. Providing a correction to the individuals separation document showing that the individual was separated by reason...
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2013 | PD-2013-01602
DATE OF PLACEMENT ON TDRL: 20030706Date of Permanent SEPARATION: 20040720 BOARD FINDINGS : IAW DoDI 6040.44, provisions of DoD or Military Department regulations or guidelines relied upon by the PEB will not be considered by the Board to the extent they were inconsistent with the VASRD in effect at the time of the adjudication.The Board did not surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD were exercised.In the matter of the asthma condition and...
AF | PDBR | CY2011 | PD2011-00850
Asthma Condition . In the matter of the asthma condition, the Board unanimously recommends a TDRL and permanent service disability rating of 30%, coded 6602 IAW VASRD §4.97. Subj: PHYSICAL DISABILITY BOARD OF REVIEW (PDBR) RECOMMENDATIONS
AF | PDBR | CY2011 | PD 2011 01084
TDRL Rating Chart Final Service IPEB Dated 20021001 VA All Effective Date 20030911 Condition Code Rating Condition Code Rating Exam On TDRL 20010813 TDRL Sep. Asthma 6602 30% 0% Asthma 6602 30%* 20031023 .No Additional MEB/PEB Entries. The PEB rated the condition as 6602 asthma, bronchial and assigned a 30% disability stating the asthma condition was only moderately controlled on multiple medications, including daily inhaled anti-inflammatory aerosols. RECOMMENDATION: The Board...
AF | PDBR | CY2013 | PD-2013-01552
The service treatment record (STR) initially reflected that the CI wasbeing worked-up for a respiratory condition noting the first of many spirometry/pulmonary function tests (PFTs) dated 28 August 2002. The CI was never placed on oral corticosteroids; therefore, Board members deliberated if the CI’s condition supported the 30% criteria level.Clearly, the final pulmonology report noted no use of medication for the previous “several months.”Additionally, the post-separation VA examination...
AF | PDBR | CY2013 | PD-2013-01908
Separation Date: 20040617 RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge with severance pay be recharacterized to reflect permanent disability retirement, effective as of the date of his prior medical separation: Physical Disability Board of Review
AF | PDBR | CY2012 | PD-2012-00374
The CI was medically separated with a 10% disability rating. At TDRL entry, the PEB adjudicated the CI’s asthma condition using VASRD code 6602, Asthma, and rated it 30% based on daily medication use. Although the TDRL re‐evaluation exam 6 months prior to separation documented daily Advair use, the PEB’s proceedings document suggested they required a medication profile be submitted as proof of medication use required to meet the 30% rating threshold.
AF | PDBR | CY2012 | PD-2012-01076
The MEB forwarded no other conditions for Physical Evaluation Board (PEB) adjudication. The MEB physical exam noted clear lungs and the medications and PFTs are summarized above. Allergy/Immunology clinic follow‐up the month after the MEB continued the diagnosis and is summarized above.